Physicians Realty Trust (NYSE:DOC) – Equities research analysts at SunTrust Banks cut their Q2 2018 earnings per share (EPS) estimates for Physicians Realty Trust in a research report issued to clients and investors on Wednesday, according to Zacks Investment Research. SunTrust Banks analyst E. Fleming now forecasts that the real estate investment trust will post earnings per share of $0.27 for the quarter, down from their previous estimate of $0.30. SunTrust Banks has a “Hold” rating and a $16.00 price objective on the stock. SunTrust Banks also issued estimates for Physicians Realty Trust’s Q3 2018 earnings at $0.29 EPS, Q4 2018 earnings at $0.29 EPS, Q1 2019 earnings at $0.30 EPS, Q2 2019 earnings at $0.30 EPS, Q3 2019 earnings at $0.27 EPS and Q4 2019 earnings at $0.30 EPS.
A number of other research firms also recently issued reports on DOC. Zacks Investment Research downgraded shares of Physicians Realty Trust from a “hold” rating to a “sell” rating in a research note on Tuesday, January 30th. Raymond James Financial set a $20.00 price target on shares of Physicians Realty Trust and gave the company a “buy” rating in a research note on Thursday, December 7th. Robert W. Baird set a $17.00 price objective on shares of Physicians Realty Trust and gave the company a “buy” rating in a research report on Friday, March 2nd. Royal Bank of Canada reiterated a “buy” rating and set a $21.00 price objective on shares of Physicians Realty Trust in a research report on Wednesday, November 15th. Finally, B. Riley set a $17.50 price objective on shares of Physicians Realty Trust and gave the company a “buy” rating in a research report on Thursday, March 1st. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and twelve have issued a buy rating to the stock. Physicians Realty Trust has a consensus rating of “Buy” and a consensus price target of $18.64.
Physicians Realty Trust (NYSE:DOC) remained flat at $$15.10 during trading on Monday. 1,340,000 shares of the company’s stock were exchanged, compared to its average volume of 1,710,000. The company has a market cap of $2,740.00, a PE ratio of 65.65, a P/E/G ratio of 2.98 and a beta of 0.53. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.58. Physicians Realty Trust has a twelve month low of $14.13 and a twelve month high of $21.85.
Physicians Realty Trust (NYSE:DOC) last released its quarterly earnings results on Wednesday, February 28th. The real estate investment trust reported $0.27 earnings per share (EPS) for the quarter, meeting the Zacks’ consensus estimate of $0.27. The company had revenue of $97.30 million for the quarter, compared to the consensus estimate of $98.56 million. Physicians Realty Trust had a net margin of 11.04% and a return on equity of 1.63%. Physicians Realty Trust’s revenue was up 32.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.27 earnings per share.
In related news, Director Tommy G. Thompson purchased 2,705 shares of the business’s stock in a transaction dated Thursday, December 14th. The shares were purchased at an average cost of $18.46 per share, for a total transaction of $49,934.30. Following the completion of the acquisition, the director now owns 49,339 shares in the company, valued at approximately $910,797.94. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Tommy G. Thompson purchased 13,650 shares of the business’s stock in a transaction dated Tuesday, March 6th. The stock was bought at an average price of $14.71 per share, for a total transaction of $200,791.50. The disclosure for this purchase can be found here. Corporate insiders own 0.51% of the company’s stock.
Several hedge funds and other institutional investors have recently bought and sold shares of the company. Cambridge Investment Research Advisors Inc. grew its holdings in shares of Physicians Realty Trust by 6.7% in the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 58,036 shares of the real estate investment trust’s stock worth $1,044,000 after purchasing an additional 3,647 shares during the last quarter. Rehmann Capital Advisory Group bought a new position in Physicians Realty Trust during the 4th quarter worth about $1,220,000. Xact Kapitalforvaltning AB bought a new position in Physicians Realty Trust during the 4th quarter worth about $262,000. Brookfield Asset Management Inc. bought a new position in Physicians Realty Trust during the 4th quarter worth about $70,764,000. Finally, MetLife Investment Advisors LLC bought a new position in Physicians Realty Trust during the 4th quarter worth about $1,478,000. Hedge funds and other institutional investors own 94.06% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This report was reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this report on another website, it was illegally copied and reposted in violation of US & international trademark and copyright laws. The original version of this report can be accessed at https://ledgergazette.com/2018/03/14/suntrust-banks-equities-analysts-lower-earnings-estimates-for-physicians-realty-trust-doc.html.
Physicians Realty Trust Company Profile
Physicians Realty Trust (the Trust) is a real estate investment trust. Physicians Realty L.P. is the operating partnership of the Trust. The Trust and its operating partnership are engaged in acquiring, developing, owning and managing healthcare properties that are leased to physicians, hospitals and healthcare delivery systems.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Physicians Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physicians Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.